Acutus Medical, Inc.’s initial public offering (IPO) will give the company up to $166m to help take on its much larger competitors in the electrophysiology sector, such as Johnson & Johnson/Biosense Webster and Abbott .
“The offering was very well-received, and we're really pleased with the outcome,” Acutus CEO Vince Burgess told